Señales en vivo de REPL | Maximiza tus Ganancias con Getagraph.com

COMPRAR 117475 min ago

@ $6.89

Emitido: 14 feb 2024 @ 14:38

Retorno: 0.87%

Señal anterior: feb 14 - 13:38

Señal anterior: Vender

Retorno: -2.96 %

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Stats
Volumen de hoy	631 256
Volumen promedio	1.14M
Capitalización de mercado	426.65M
EPS	$0 ( 2024-02-08 )
Próxima fecha de ganancias	( $-0.860 ) 2024-05-16
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.20
ATR14	$0.00900 (0.13%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Peeples-dyer Veleka	Buy	32 000	Stock Option (right to buy)
2024-04-01	Patel Sushil	Buy	250 000	Employee Stock Option (right to buy)
2024-04-01	Patel Sushil	Buy	83 335	Common Stock
2024-04-01	Pucci Paolo	Buy	32 000	Stock Option (right to buy)
2024-04-01	Xynos Konstantinos	Buy	26 665	Common Stock

INSIDER POWER
74.56
Last 98 transactions
Buy: 2 588 053 \| Sell: 457 936

Volumen Correlación

Largo: -0.17 (neutral)

Corto: -0.86 (strong negative)

Signal:(43.047) Neutral

Replimune Group Inc Correlación

10 Correlaciones Más Positivas
BNIXU	0.927
CASS	0.908
ATIF	0.895
COLL	0.894
COFS	0.893
CNXC	0.893
NIU	0.888
FCBP	0.887
DRTT	0.884
BTAI	0.882

10 Correlaciones Más Negativas
MTEK	-0.873
NGMS	-0.849
CRSA	-0.842
PPBT	-0.839
RMRM	-0.833
PLMR	-0.83
SLDP	-0.828
OSMT	-0.828
MVBF	-0.821
TCRX	-0.821

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Replimune Group Inc Correlación - Moneda/Commodity

-0.13
( neutral )

-0.28
( neutral )

0.00
( neutral )

-0.42
( neutral )

0.16
( neutral )

0.40
( neutral )

Replimune Group Inc Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-2.45M (0.00 %)
EPS:	$-2.99

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-2.45M (0.00 %)
EPS:	$-2.99

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-4.58M (0.00 %)
EPS:	$-2.26

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.750

Financial Reports:

No articles found.

Replimune Group Inc

Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Phase II clinical trials for patients with cutaneous squamous cell carcinoma. It is also developing RP2, which is in Phase I clinical trials for an anti-CTLA-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trials to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.